Research Idea
Research content for general circulation. Not individualized advice.Ā Methodology & Disclosures
Strong Q3 fiscal 2026 ARR growth (11% YoY), AI partnerships, and a ~30% price surge with positive technical breakout highlight UiPathās accelerating automation momentum, framing it as a high-conviction short-term buy despite governance and macro risks.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Price Behavior
Key Price Behavior Insights: ā¢ Higher lows ā¢ Sharp reversal ā¢ Support test Support Level: $10.70-$10.53 Resistance Level: $12.0-$12.2 Over the last month, PATH stayed modestly higher overall but reversed sharply after a run-up to $12.16, leaving $12.0-$12.2 as resistance and $10.70-$10.53 as key support.
Sentiment & News
Key News Insights: ā¢ Profitability Gains ā¢ AI Catalyst ā¢ Volatility Risk UiPath's July 2026 news highlighted improving profitability, ARR growth, and AI-orchestration momentum, but ongoing stock volatility and concerns about AI cannibalizing legacy RPA demand kept sentiment cautious.
AI Summary
UiPath is now less a ārecovering software stockā and more a high-stakes bet that agentic AI can scale into a real commercial platform before legacy RPA demand erodes, with its strong cash/no-debt balance sheet buying time but the investment case still hinging on sustained ARR acceleration, pilot-to-production conversion, and durable margin/free-cash-flow improvement.
Description
UiPath Inc. sells an end-to-end robotic process automation platform that helps organizations design, deploy and govern software robots and related machine-learning models, with major operations in the United States, Romania and Japan. The platform combines AI-driven process discovery, low-code development, orchestration for attended and unattended bots, application connectors and centralized tools for testing, monitoring and compliance; the company also offers maintenance, training and implementation services. Customers include banks, healthcare providers, financial services firms and government agencies; the company was founded in 2005 and is headquartered in New York, NY.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 8 | Dec 15 | PATH | UiPath Inc. | Strong Q3 fiscal 2026 ARR growth (11% YoY), AI partnerships, and a ~30% price surge with positive technical breakout highlight UiPathās accelerating automation momentum, framing it as a high-conviction short-term buy despite governance and macro risks. | Closed | -16.2% |